Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 11:7:611017.
doi: 10.3389/fmolb.2020.611017. eCollection 2020.

Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses

Affiliations
Review

Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses

Wei Jian Tan et al. Front Mol Biosci. .

Abstract

Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that manifests as diffuse large B-cell lymphoma. Early and accurate diagnosis is essential to prevent mistreatment and to reduce the high morbidity and mortality associated with VRL. The disease can be diagnosed using various methods, including cytology, immunohistochemistry, cytokine analysis, flow cytometry, and molecular analysis of bulk vitreous aspirates. Despite these options, VRL diagnosis remains challenging, as samples are often confounded by low cellularity, the presence of debris and non-target immunoreactive cells, and poor cytological preservation. As such, VRL diagnostic accuracy is limited by both false-positive and false-negative outcomes. Missed or inappropriate diagnosis may cause delays in treatment, which can have life-threatening consequences for patients with VRL. In this review, we summarize current knowledge and the diagnostic modalities used for VRL diagnosis. We also highlight several emerging molecular techniques, including high-resolution single cell-based analyses, which may enable more comprehensive and precise VRL diagnoses.

Keywords: cytology; diffuse large B-cell lymphoma; molecular diagnostics; precision medicine; single-cell analysis; vitreoretinal lymphoma.

PubMed Disclaimer

Conflict of interest statement

WJT and TSL were employees and PR-C a consultant for A. Menarini Biomarkers Singapore Pte Ltd. ASYC received research funding from A. Menarini Biomarkers Singapore Pte Ltd. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of bulk cell-vs. single cell-based MYD88 analysis. (A) A heterogeneous cellular sample with MYD88WT (red) or MYD88L265P mutants (blue) was lysed for bulk-cell myeloid differentiation primary response 88 (MYD88) analysis. (B) An electropherogram showing sequencing peaks for MYD88WT and MYD88L265P. The black arrows throughout indicate the location of a T→C point mutation corresponding to MYD88WT (CTG) or MYD88L265P (CCG), respectively. (C) Individual cells with MYD88WT (red/red), heterozygous (red/blue), or homozygous MYD88L265P mutant (blue/blue) were isolated and lysed for single cell-based MYD88 analysis. (D) An electropherogram showing clean and well-resolved sequencing peaks for MYD88WT, heterozygous (red/blue), or homozygous MYD88L265P alleles from the single cells. The black arrows throughout indicate the location of a T→C point mutation corresponding to MYD88WT (CTG) or MYD88L265P (CCG), respectively. WT, wild-type MYD88WT; mutant, MYD88L265P.

Similar articles

Cited by

References

    1. Akkaya B., Salim O., Akkaya H., Ozcan M., Yucel O. K., Erdem R., et al. . (2016). C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: a study of 97 patients. Indian J. Pathol. Microbiol 59, 41–46. 10.4103/0377-4929.178220 - DOI - PubMed
    1. Akpek E. K., Foster C. S. (2000). Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene arrangement. Arch. Ophthalmol. 118, 731–732. 10.1001/archopht.117.9.1239 - DOI - PubMed
    1. Akpek E. K., Maca S. M., Christen W. G., Foster C. S. (1999). Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology 106, 2291–2295. 10.1016/S0161-6420(99)90528-6 - DOI - PubMed
    1. Alas S., Bonavida B. (2001). Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res. 61, 5137–5144. - PubMed
    1. Alizadeh A. A., Eisen M. B., Davis R. E., Ma C., Lossos I. S., Rosenwald A., et al. . (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511. 10.1038/35000501 - DOI - PubMed